- Home
- GDS vs ALKS Comparison
GDS vs ALKS Comparison
Compare GDS & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDS
- ALKS
- Stock Information
- Founded
- GDS 2001
- ALKS 1987
- Country
- GDS China
- ALKS Ireland
- Employees
- GDS N/A
- ALKS N/A
- Industry
- GDS Computer Software: Programming Data Processing
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- GDS Technology
- ALKS Health Care
- Exchange
- GDS Nasdaq
- ALKS Nasdaq
- Market Cap
- GDS 5.5B
- ALKS 5.1B
- IPO Year
- GDS 2016
- ALKS 1991
- Fundamental
- Price
- GDS $29.39
- ALKS $29.05
- Analyst Decision
- GDS Strong Buy
- ALKS Buy
- Analyst Count
- GDS 5
- ALKS 12
- Target Price
- GDS $39.48
- ALKS $40.00
- AVG Volume (30 Days)
- GDS 1.6M
- ALKS 1.7M
- Earning Date
- GDS 08-20-2025
- ALKS 07-23-2025
- Dividend Yield
- GDS N/A
- ALKS N/A
- EPS Growth
- GDS N/A
- ALKS N/A
- EPS
- GDS 3.31
- ALKS 2.09
- Revenue
- GDS $1,462,549,715.00
- ALKS $1,513,770,000.00
- Revenue This Year
- GDS $15.11
- ALKS N/A
- Revenue Next Year
- GDS $13.47
- ALKS $4.25
- P/E Ratio
- GDS $258.63
- ALKS $13.86
- Revenue Growth
- GDS 8.23
- ALKS N/A
- 52 Week Low
- GDS $9.22
- ALKS $22.90
- 52 Week High
- GDS $52.50
- ALKS $36.45
- Technical
- Relative Strength Index (RSI)
- GDS 63.84
- ALKS 40.26
- Support Level
- GDS $29.31
- ALKS $29.26
- Resistance Level
- GDS $30.95
- ALKS $29.53
- Average True Range (ATR)
- GDS 0.93
- ALKS 0.69
- MACD
- GDS 0.39
- ALKS -0.14
- Stochastic Oscillator
- GDS 87.69
- ALKS 14.74
About GDS GDS Holdings Limited ADS
GDS Holdings started as an IT service provider in 2001 then moved to the data center business with its first self-developed data center opening in 2010. The company now develops and operates data centers in China and also builds, operates and transfers data centers for other clients. It offers colocation and managed services and mainly targets hyperscale cloud service customers who take large areas of its data centers or even whole data centers under long-term contracts. Its data centers are located predominantly in and around the Tier 1 cities in China and it has also started an expanding into Southeast Asia via the now 38% owned DayOne. GDS listed on the Nasdaq in 2016 and completed a secondary listing in Hong Kong in 2020.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.